Industry Research Reports

Home > Reports > Pharma & Healthcare > Heparin Anticoagulant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Heparin Anticoagulant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 128 Pages

Report ld: 2622708

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

The global market for Heparin Anticoagulant was estimated to be worth US$ 1816 million in 2023 and is forecast to a readjusted size of US$ 2274.5 million by 2030 with a CAGR of 3.2% during the forecast period 2024-2030

Heparin Anticoagulant Market Size

M= millions and B=billions

Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.

North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin Anticoagulant, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin Anticoagulant by region & country, by Type, and by Application.

The Heparin Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Anticoagulant.

Market Segmentation

Report Metric
Details
Report Title
Heparin Anticoagulant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 2274.5 million
CAGR(2024-2030)
3.2%
Market Size Available for Years
2019-2030
Global Heparin Anticoagulant Companies Covered
Aspen Pharmacare Holdings, Baxter International, GlaxoSmithKline, Dr. Reddy’s Laboratories, Fresenius Kabi, Leo Pharma, Mylan, Novartis, Pfizer, Sanofi, Syntex, Teva
Global Heparin Anticoagulant Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Heparin Anticoagulant Market, Segment by Type
Unfractionated Heparin (UF)

Low Molecular Weight Heparin (LMWH)

Ultra-low Molecular Weight Heparin (ULMWH)
Global Heparin Anticoagulant Market, Segment by Application
Assisted Living Facilities

Home Healthcare

Hospitals

Nursing Homes and Private Clinics
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Heparin Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Heparin Anticoagulant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Heparin Anticoagulant in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Heparin Anticoagulant Product Introduction
    1.2 Global Heparin Anticoagulant Market Size Forecast
        1.2.1 Global Heparin Anticoagulant Sales Value (2019-2030)
        1.2.2 Global Heparin Anticoagulant Sales Volume (2019-2030)
        1.2.3 Global Heparin Anticoagulant Sales Price (2019-2030)
    1.3 Heparin Anticoagulant Market Trends & Drivers
        1.3.1 Heparin Anticoagulant Industry Trends
        1.3.2 Heparin Anticoagulant Market Drivers & Opportunity
        1.3.3 Heparin Anticoagulant Market Challenges
        1.3.4 Heparin Anticoagulant Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Heparin Anticoagulant Players Revenue Ranking (2023)
    2.2 Global Heparin Anticoagulant Revenue by Company (2019-2024)
    2.3 Global Heparin Anticoagulant Players Sales Volume Ranking (2023)
    2.4 Global Heparin Anticoagulant Sales Volume by Company Players (2019-2024)
    2.5 Global Heparin Anticoagulant Average Price by Company (2019-2024)
    2.6 Key Manufacturers Heparin Anticoagulant Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Heparin Anticoagulant Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Heparin Anticoagulant
    2.9 Heparin Anticoagulant Market Competitive Analysis
        2.9.1 Heparin Anticoagulant Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Heparin Anticoagulant Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Anticoagulant as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Unfractionated Heparin (UF)
        3.1.2 Low Molecular Weight Heparin (LMWH)
        3.1.3 Ultra-low Molecular Weight Heparin (ULMWH)
    3.2 Global Heparin Anticoagulant Sales Value by Type
        3.2.1 Global Heparin Anticoagulant Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Heparin Anticoagulant Sales Value, by Type (2019-2030)
        3.2.3 Global Heparin Anticoagulant Sales Value, by Type (%) (2019-2030)
    3.3 Global Heparin Anticoagulant Sales Volume by Type
        3.3.1 Global Heparin Anticoagulant Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Heparin Anticoagulant Sales Volume, by Type (2019-2030)
        3.3.3 Global Heparin Anticoagulant Sales Volume, by Type (%) (2019-2030)
    3.4 Global Heparin Anticoagulant Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Assisted Living Facilities
        4.1.2 Home Healthcare
        4.1.3 Hospitals
        4.1.4 Nursing Homes and Private Clinics
    4.2 Global Heparin Anticoagulant Sales Value by Application
        4.2.1 Global Heparin Anticoagulant Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Heparin Anticoagulant Sales Value, by Application (2019-2030)
        4.2.3 Global Heparin Anticoagulant Sales Value, by Application (%) (2019-2030)
    4.3 Global Heparin Anticoagulant Sales Volume by Application
        4.3.1 Global Heparin Anticoagulant Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Heparin Anticoagulant Sales Volume, by Application (2019-2030)
        4.3.3 Global Heparin Anticoagulant Sales Volume, by Application (%) (2019-2030)
    4.4 Global Heparin Anticoagulant Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Heparin Anticoagulant Sales Value by Region
        5.1.1 Global Heparin Anticoagulant Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Heparin Anticoagulant Sales Value by Region (2019-2024)
        5.1.3 Global Heparin Anticoagulant Sales Value by Region (2025-2030)
        5.1.4 Global Heparin Anticoagulant Sales Value by Region (%), (2019-2030)
    5.2 Global Heparin Anticoagulant Sales Volume by Region
        5.2.1 Global Heparin Anticoagulant Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Heparin Anticoagulant Sales Volume by Region (2019-2024)
        5.2.3 Global Heparin Anticoagulant Sales Volume by Region (2025-2030)
        5.2.4 Global Heparin Anticoagulant Sales Volume by Region (%), (2019-2030)
    5.3 Global Heparin Anticoagulant Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Heparin Anticoagulant Sales Value, 2019-2030
        5.4.2 North America Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Heparin Anticoagulant Sales Value, 2019-2030
        5.5.2 Europe Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Heparin Anticoagulant Sales Value, 2019-2030
        5.6.2 Asia Pacific Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Heparin Anticoagulant Sales Value, 2019-2030
        5.7.2 South America Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Heparin Anticoagulant Sales Value, 2019-2030
        5.8.2 Middle East & Africa Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Heparin Anticoagulant Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Heparin Anticoagulant Sales Value
        6.2.1 Key Countries/Regions Heparin Anticoagulant Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Heparin Anticoagulant Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Heparin Anticoagulant Sales Value, 2019-2030
        6.3.2 United States Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Heparin Anticoagulant Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Heparin Anticoagulant Sales Value, 2019-2030
        6.4.2 Europe Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Heparin Anticoagulant Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Heparin Anticoagulant Sales Value, 2019-2030
        6.5.2 China Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Heparin Anticoagulant Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Heparin Anticoagulant Sales Value, 2019-2030
        6.6.2 Japan Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Heparin Anticoagulant Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Heparin Anticoagulant Sales Value, 2019-2030
        6.7.2 South Korea Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Heparin Anticoagulant Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Heparin Anticoagulant Sales Value, 2019-2030
        6.8.2 Southeast Asia Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Heparin Anticoagulant Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Heparin Anticoagulant Sales Value, 2019-2030
        6.9.2 India Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Heparin Anticoagulant Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Aspen Pharmacare Holdings
        7.1.1 Aspen Pharmacare Holdings Company Information
        7.1.2 Aspen Pharmacare Holdings Introduction and Business Overview
        7.1.3 Aspen Pharmacare Holdings Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Aspen Pharmacare Holdings Heparin Anticoagulant Product Offerings
        7.1.5 Aspen Pharmacare Holdings Recent Development
    7.2 Baxter International
        7.2.1 Baxter International Company Information
        7.2.2 Baxter International Introduction and Business Overview
        7.2.3 Baxter International Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Baxter International Heparin Anticoagulant Product Offerings
        7.2.5 Baxter International Recent Development
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Company Information
        7.3.2 GlaxoSmithKline Introduction and Business Overview
        7.3.3 GlaxoSmithKline Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 GlaxoSmithKline Heparin Anticoagulant Product Offerings
        7.3.5 GlaxoSmithKline Recent Development
    7.4 Dr. Reddy’s Laboratories
        7.4.1 Dr. Reddy’s Laboratories Company Information
        7.4.2 Dr. Reddy’s Laboratories Introduction and Business Overview
        7.4.3 Dr. Reddy’s Laboratories Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Dr. Reddy’s Laboratories Heparin Anticoagulant Product Offerings
        7.4.5 Dr. Reddy’s Laboratories Recent Development
    7.5 Fresenius Kabi
        7.5.1 Fresenius Kabi Company Information
        7.5.2 Fresenius Kabi Introduction and Business Overview
        7.5.3 Fresenius Kabi Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Fresenius Kabi Heparin Anticoagulant Product Offerings
        7.5.5 Fresenius Kabi Recent Development
    7.6 Leo Pharma
        7.6.1 Leo Pharma Company Information
        7.6.2 Leo Pharma Introduction and Business Overview
        7.6.3 Leo Pharma Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Leo Pharma Heparin Anticoagulant Product Offerings
        7.6.5 Leo Pharma Recent Development
    7.7 Mylan
        7.7.1 Mylan Company Information
        7.7.2 Mylan Introduction and Business Overview
        7.7.3 Mylan Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Mylan Heparin Anticoagulant Product Offerings
        7.7.5 Mylan Recent Development
    7.8 Novartis
        7.8.1 Novartis Company Information
        7.8.2 Novartis Introduction and Business Overview
        7.8.3 Novartis Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Novartis Heparin Anticoagulant Product Offerings
        7.8.5 Novartis Recent Development
    7.9 Pfizer
        7.9.1 Pfizer Company Information
        7.9.2 Pfizer Introduction and Business Overview
        7.9.3 Pfizer Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Pfizer Heparin Anticoagulant Product Offerings
        7.9.5 Pfizer Recent Development
    7.10 Sanofi
        7.10.1 Sanofi Company Information
        7.10.2 Sanofi Introduction and Business Overview
        7.10.3 Sanofi Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Sanofi Heparin Anticoagulant Product Offerings
        7.10.5 Sanofi Recent Development
    7.11 Syntex
        7.11.1 Syntex Company Information
        7.11.2 Syntex Introduction and Business Overview
        7.11.3 Syntex Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Syntex Heparin Anticoagulant Product Offerings
        7.11.5 Syntex Recent Development
    7.12 Teva
        7.12.1 Teva Company Information
        7.12.2 Teva Introduction and Business Overview
        7.12.3 Teva Heparin Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Teva Heparin Anticoagulant Product Offerings
        7.12.5 Teva Recent Development

 8 Industry Chain Analysis
    8.1 Heparin Anticoagulant Industrial Chain
    8.2 Heparin Anticoagulant Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Heparin Anticoagulant Sales Model
        8.5.2 Sales Channel
        8.5.3 Heparin Anticoagulant Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Heparin Anticoagulant Market Trends
    Table 2. Heparin Anticoagulant Market Drivers & Opportunity
    Table 3. Heparin Anticoagulant Market Challenges
    Table 4. Heparin Anticoagulant Market Restraints
    Table 5. Global Heparin Anticoagulant Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Heparin Anticoagulant Revenue Market Share by Company (2019-2024)
    Table 7. Global Heparin Anticoagulant Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Heparin Anticoagulant Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Heparin Anticoagulant Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Heparin Anticoagulant Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Heparin Anticoagulant Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Heparin Anticoagulant
    Table 13. Global Heparin Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Anticoagulant as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Heparin Anticoagulant Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Heparin Anticoagulant Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Heparin Anticoagulant Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Heparin Anticoagulant Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Heparin Anticoagulant Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Heparin Anticoagulant Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Heparin Anticoagulant Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Heparin Anticoagulant Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Heparin Anticoagulant Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Heparin Anticoagulant Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Heparin Anticoagulant Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Heparin Anticoagulant Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Heparin Anticoagulant Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Heparin Anticoagulant Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Heparin Anticoagulant Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Heparin Anticoagulant Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Heparin Anticoagulant Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Heparin Anticoagulant Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Heparin Anticoagulant Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Heparin Anticoagulant Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Heparin Anticoagulant Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Heparin Anticoagulant Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Heparin Anticoagulant Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Heparin Anticoagulant Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Heparin Anticoagulant Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Heparin Anticoagulant Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Heparin Anticoagulant Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Heparin Anticoagulant Sales Value by Region (2019-2024) & (%)
    Table 44. Global Heparin Anticoagulant Sales Value by Region (2025-2030) & (%)
    Table 45. Global Heparin Anticoagulant Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Heparin Anticoagulant Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Heparin Anticoagulant Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Heparin Anticoagulant Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Heparin Anticoagulant Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Heparin Anticoagulant Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Heparin Anticoagulant Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Heparin Anticoagulant Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Heparin Anticoagulant Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Heparin Anticoagulant Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Heparin Anticoagulant Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Heparin Anticoagulant Sales Volume, (2025-2030) & (K Units)
    Table 57. Aspen Pharmacare Holdings Company Information
    Table 58. Aspen Pharmacare Holdings Introduction and Business Overview
    Table 59. Aspen Pharmacare Holdings Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Aspen Pharmacare Holdings Heparin Anticoagulant Product Offerings
    Table 61. Aspen Pharmacare Holdings Recent Development
    Table 62. Baxter International Company Information
    Table 63. Baxter International Introduction and Business Overview
    Table 64. Baxter International Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Baxter International Heparin Anticoagulant Product Offerings
    Table 66. Baxter International Recent Development
    Table 67. GlaxoSmithKline Company Information
    Table 68. GlaxoSmithKline Introduction and Business Overview
    Table 69. GlaxoSmithKline Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. GlaxoSmithKline Heparin Anticoagulant Product Offerings
    Table 71. GlaxoSmithKline Recent Development
    Table 72. Dr. Reddy’s Laboratories Company Information
    Table 73. Dr. Reddy’s Laboratories Introduction and Business Overview
    Table 74. Dr. Reddy’s Laboratories Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Dr. Reddy’s Laboratories Heparin Anticoagulant Product Offerings
    Table 76. Dr. Reddy’s Laboratories Recent Development
    Table 77. Fresenius Kabi Company Information
    Table 78. Fresenius Kabi Introduction and Business Overview
    Table 79. Fresenius Kabi Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Fresenius Kabi Heparin Anticoagulant Product Offerings
    Table 81. Fresenius Kabi Recent Development
    Table 82. Leo Pharma Company Information
    Table 83. Leo Pharma Introduction and Business Overview
    Table 84. Leo Pharma Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Leo Pharma Heparin Anticoagulant Product Offerings
    Table 86. Leo Pharma Recent Development
    Table 87. Mylan Company Information
    Table 88. Mylan Introduction and Business Overview
    Table 89. Mylan Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Mylan Heparin Anticoagulant Product Offerings
    Table 91. Mylan Recent Development
    Table 92. Novartis Company Information
    Table 93. Novartis Introduction and Business Overview
    Table 94. Novartis Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Novartis Heparin Anticoagulant Product Offerings
    Table 96. Novartis Recent Development
    Table 97. Pfizer Company Information
    Table 98. Pfizer Introduction and Business Overview
    Table 99. Pfizer Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Pfizer Heparin Anticoagulant Product Offerings
    Table 101. Pfizer Recent Development
    Table 102. Sanofi Company Information
    Table 103. Sanofi Introduction and Business Overview
    Table 104. Sanofi Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Sanofi Heparin Anticoagulant Product Offerings
    Table 106. Sanofi Recent Development
    Table 107. Syntex Company Information
    Table 108. Syntex Introduction and Business Overview
    Table 109. Syntex Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Syntex Heparin Anticoagulant Product Offerings
    Table 111. Syntex Recent Development
    Table 112. Teva Company Information
    Table 113. Teva Introduction and Business Overview
    Table 114. Teva Heparin Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Teva Heparin Anticoagulant Product Offerings
    Table 116. Teva Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Heparin Anticoagulant Downstream Customers
    Table 120. Heparin Anticoagulant Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Heparin Anticoagulant Product Picture
    Figure 2. Global Heparin Anticoagulant Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Heparin Anticoagulant Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Heparin Anticoagulant Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Heparin Anticoagulant Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Heparin Anticoagulant Report Years Considered
    Figure 7. Global Heparin Anticoagulant Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Heparin Anticoagulant Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin Anticoagulant Revenue in 2023
    Figure 10. Heparin Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Unfractionated Heparin (UF) Picture
    Figure 12. Low Molecular Weight Heparin (LMWH) Picture
    Figure 13. Ultra-low Molecular Weight Heparin (ULMWH) Picture
    Figure 14. Global Heparin Anticoagulant Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Heparin Anticoagulant Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Heparin Anticoagulant Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Heparin Anticoagulant Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Heparin Anticoagulant Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Assisted Living Facilities
    Figure 20. Product Picture of Home Healthcare
    Figure 21. Product Picture of Hospitals
    Figure 22. Product Picture of Nursing Homes and Private Clinics
    Figure 23. Global Heparin Anticoagulant Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Heparin Anticoagulant Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Heparin Anticoagulant Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Heparin Anticoagulant Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Heparin Anticoagulant Price by Application (2019-2030) & (US$/Unit)
    Figure 28. North America Heparin Anticoagulant Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Heparin Anticoagulant Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Heparin Anticoagulant Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Heparin Anticoagulant Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Heparin Anticoagulant Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Heparin Anticoagulant Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Heparin Anticoagulant Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Heparin Anticoagulant Sales Volume (%), (2019-2030)
    Figure 40. United States Heparin Anticoagulant Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Heparin Anticoagulant Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Heparin Anticoagulant Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Heparin Anticoagulant Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Heparin Anticoagulant Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Heparin Anticoagulant Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Heparin Anticoagulant Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Heparin Anticoagulant Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Heparin Anticoagulant Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Heparin Anticoagulant Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Heparin Anticoagulant Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Heparin Anticoagulant Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Heparin Anticoagulant Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Heparin Anticoagulant Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Heparin Anticoagulant Sales Value by Application (%), 2023 VS 2030
    Figure 61. Heparin Anticoagulant Industrial Chain
    Figure 62. Heparin Anticoagulant Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Description

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

The global market for Heparin Anticoagulant was estimated to be worth US$ 1816 million in 2023 and is forecast to a readjusted size of US$ 2274.5 million by 2030 with a CAGR of 3.2% during the forecast period 2024-2030

Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.

North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin Anticoagulant, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin Anticoagulant by region & country, by Type, and by Application.

The Heparin Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Anticoagulant.

Market Segmentation